Development of a 23-Gene Signature for Tumor Growth Mechanism in Vestibular Schwannoma
2024

23-Gene Signature for Tumor Growth in Vestibular Schwannoma

Sample size: 210 publication Evidence: moderate

Author Information

Author(s): Sung Ji-Yong, Lee Jung Woo, Qoronfleh M. Walid, Al-Dewik Nader

Primary Institution: Department of Research & Development, VeraOmics, Republic of Korea

Hypothesis

This study aimed to investigate the mechanisms of tumor growth using bulk RNA-seq and single-cell data from patients with vestibular schwannomas.

Conclusion

The research identified 23 specific genes that are potential predictors and prognostic biomarkers for direct medical therapy in patients with vestibular schwannoma.

Supporting Evidence

  • The study identified 23 genes related to signal transduction that are important for tumor growth.
  • These findings suggest potential biomarkers that could help predict tumor behavior.
  • The research lays the groundwork for future personalized treatments for vestibular schwannomas.

Takeaway

Scientists found 23 important genes that can help doctors understand how a type of tumor grows and how to treat it better.

Methodology

The study used bulk RNA-seq and single-cell RNA-seq data from 210 patients to analyze tumor growth mechanisms.

Limitations

The findings need to be prospectively verified using large patient cohorts.

Participant Demographics

Patients with vestibular schwannomas, including data from 210 patients and 33,081 single cells.

Statistical Information

P-Value

p = 0.019; LGG, p = 1.5 × 10−10

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/cancers16244134

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication